_id

690daf15ccc777a4e85d0adc

Ticker

ANNX

Name

Annexon Inc

Exchange

NASDAQ

Address

1400 Sierra Point Parkway, Brisbane, CA, United States, 94005

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.annexonbio.com

Description

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.

Last Close

5.04

Volume

3045876

Current Price

4.97

Change

-1.3888888888888946

Last Updated

2025-11-28T12:15:08.535Z

Image

-

Ipo Date

2020-07-24T00:00:00.000Z

Market Cap

643921408

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.905

Sentiment Sources

5

Rating

4.625

Target Price

14

Strong Buy

5

Buy

3

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

57018000

Operating Income

-57018000

Interest Expense

-

Pretax Income

-54922000

Net Income

-54922000

Eps

-0.36829826266181526

Dividends Per Share

-

Shares Outstanding

149055879

Income Tax Expense

-

EBITDA

-54376000

Operating Margin

-

Total Other Income Expense Net

2096000

Cash

139419000

Short Term Investments

49302000

Receivables

-

Inventories

-

Total Current Assets

192822000

Property Plant Equipment

26739000

Total Assets

229142000

Payables

18219000

Short Term Debt

2818000

Long Term Debt

-

Total Liabilities

67700000

Equity

161442000

Depreciation

546000

Change In Working Capital

-1675000

Cash From Operations

-52304000

Capital Expenditures

48000

Cash From Investing

45871000

Cash From Financing

13564000

Net Change In Cash

7131000

PE

-

PB

4.590780552582352

ROE

-34.019647923093125

ROA

-23.96854352323014

FCF

-52352000

Fcf Percent

-

Piotroski FScore

1

Health Score

38

Deep Value Investing Score

3.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

3.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

57018000

Quarters > 0 > income Statement > operating Income

-57018000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-54922000

Quarters > 0 > income Statement > net Income

-54922000

Quarters > 0 > income Statement > eps

-0.36829826266181526

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

149123701

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-54376000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

2096000

Quarters > 0 > balance Sheet > cash

139419000

Quarters > 0 > balance Sheet > short Term Investments

49302000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

192822000

Quarters > 0 > balance Sheet > property Plant Equipment

26739000

Quarters > 0 > balance Sheet > total Assets

229142000

Quarters > 0 > balance Sheet > payables

18219000

Quarters > 0 > balance Sheet > short Term Debt

2818000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

67700000

Quarters > 0 > balance Sheet > equity

161442000

Quarters > 0 > cash Flow > net Income

-54922000

Quarters > 0 > cash Flow > depreciation

546000

Quarters > 0 > cash Flow > change In Working Capital

-1675000

Quarters > 0 > cash Flow > cash From Operations

-52304000

Quarters > 0 > cash Flow > capital Expenditures

48000

Quarters > 0 > cash Flow > cash From Investing

45871000

Quarters > 0 > cash Flow > cash From Financing

13564000

Quarters > 0 > cash Flow > net Change In Cash

7131000

Quarters > 0 > ratios > PE

-0.36829826266181526

Quarters > 0 > ratios > PB

4.590780552582352

Quarters > 0 > ratios > ROE

-34.019647923093125

Quarters > 0 > ratios > ROA

-23.96854352323014

Quarters > 0 > ratios > FCF

-52352000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

38

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

912000

Quarters > 1 > income Statement > gross Profit

-912000

Quarters > 1 > income Statement > operating Expenses

51726000

Quarters > 1 > income Statement > operating Income

-51726000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-49156000

Quarters > 1 > income Statement > net Income

-49156000

Quarters > 1 > income Statement > eps

-0.33141676019647764

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

148320803

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-51111000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

2570000

Quarters > 1 > balance Sheet > cash

132288000

Quarters > 1 > balance Sheet > short Term Investments

94729000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

230620000

Quarters > 1 > balance Sheet > property Plant Equipment

27624000

Quarters > 1 > balance Sheet > total Assets

264573000

Quarters > 1 > balance Sheet > payables

11515000

Quarters > 1 > balance Sheet > short Term Debt

2716000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

65556000

Quarters > 1 > balance Sheet > equity

199017000

Quarters > 1 > cash Flow > net Income

-49156000

Quarters > 1 > cash Flow > depreciation

540000

Quarters > 1 > cash Flow > change In Working Capital

7224000

Quarters > 1 > cash Flow > cash From Operations

-38071000

Quarters > 1 > cash Flow > capital Expenditures

15000

Quarters > 1 > cash Flow > cash From Investing

73082000

Quarters > 1 > cash Flow > cash From Financing

153000

Quarters > 1 > cash Flow > net Change In Cash

35166000

Quarters > 1 > ratios > PE

-0.33141676019647764

Quarters > 1 > ratios > PB

3.703977001512434

Quarters > 1 > ratios > ROE

-24.69939753890371

Quarters > 1 > ratios > ROA

-18.579371288831435

Quarters > 1 > ratios > FCF

-38086000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

38

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

896000

Quarters > 2 > income Statement > gross Profit

-896000

Quarters > 2 > income Statement > operating Expenses

57405000

Quarters > 2 > income Statement > operating Income

-57405000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-54356000

Quarters > 2 > income Statement > net Income

-54356000

Quarters > 2 > income Statement > eps

-0.3670004530250459

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

148108809

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-56868000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

3049000

Quarters > 2 > balance Sheet > cash

97122000

Quarters > 2 > balance Sheet > short Term Investments

166574000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

268162000

Quarters > 2 > balance Sheet > property Plant Equipment

28536000

Quarters > 2 > balance Sheet > total Assets

303027000

Quarters > 2 > balance Sheet > payables

10437000

Quarters > 2 > balance Sheet > short Term Debt

2616000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

59239000

Quarters > 2 > balance Sheet > equity

243788000

Quarters > 2 > cash Flow > net Income

-54356000

Quarters > 2 > cash Flow > depreciation

537000

Quarters > 2 > cash Flow > change In Working Capital

177000

Quarters > 2 > cash Flow > cash From Operations

-50055000

Quarters > 2 > cash Flow > capital Expenditures

74000

Quarters > 2 > cash Flow > cash From Investing

97620000

Quarters > 2 > cash Flow > cash From Financing

59000

Quarters > 2 > cash Flow > net Change In Cash

47624000

Quarters > 2 > ratios > PE

-0.3670004530250459

Quarters > 2 > ratios > PB

3.0194299175102954

Quarters > 2 > ratios > ROE

-22.296421480958866

Quarters > 2 > ratios > ROA

-17.937675520663177

Quarters > 2 > ratios > FCF

-50129000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

38

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

3404000

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

1702000

Quarters > 3 > income Statement > operating Expenses

52479000

Quarters > 3 > income Statement > operating Income

-52479000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-48590000

Quarters > 3 > income Statement > net Income

-48590000

Quarters > 3 > income Statement > eps

-0.32872802887123764

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

147812160

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-51942000

Quarters > 3 > income Statement > operating Margin

-1541.68625146886

Quarters > 3 > income Statement > total Other Income Expense Net

3889000

Quarters > 3 > balance Sheet > cash

49498000

Quarters > 3 > balance Sheet > short Term Investments

262519000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

316461000

Quarters > 3 > balance Sheet > property Plant Equipment

29343000

Quarters > 3 > balance Sheet > total Assets

350071000

Quarters > 3 > balance Sheet > payables

10426000

Quarters > 3 > balance Sheet > short Term Debt

2518000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

56966000

Quarters > 3 > balance Sheet > equity

293105000

Quarters > 3 > cash Flow > net Income

-48590000

Quarters > 3 > cash Flow > depreciation

537000

Quarters > 3 > cash Flow > change In Working Capital

9493000

Quarters > 3 > cash Flow > cash From Operations

-36015000

Quarters > 3 > cash Flow > capital Expenditures

6000

Quarters > 3 > cash Flow > cash From Investing

1012000

Quarters > 3 > cash Flow > cash From Financing

4967000

Quarters > 3 > cash Flow > net Change In Cash

-30042000

Quarters > 3 > ratios > PE

-0.32872802887123764

Quarters > 3 > ratios > PB

2.5063592746626635

Quarters > 3 > ratios > ROE

-16.57767694171031

Quarters > 3 > ratios > ROA

-13.88004147730032

Quarters > 3 > ratios > FCF

-36021000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-10.581962397179788

Quarters > 3 > health Score

35

Valuation > metrics > PE

-0.36829826266181526

Valuation > metrics > PB

4.590780552582352

Valuation > final Score

34.09219447417648

Valuation > verdict

53.0% Overvalued

Profitability > metrics > ROE

-34.019647923093125

Profitability > metrics > ROA

-28.483264357801495

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.41934564735322905

Risk > metrics > Interest Coverage

-104.42857142857143

Risk > final Score

-358

Risk > verdict

High

Liquidity > metrics > Current Ratio

9.165850644103246

Liquidity > metrics > Quick Ratio

9.165850644103246

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

42.96022998487566

Prev Valuations > 1

49.805700824897045

Prev Valuations > 2

80

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-46

Prev Risks > 1

-31

Prev Risks > 2

-3

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:13:45.282Z